Dementia is a neurological disease that mainly affects the elderly. A recent finding shows that one everyday drink can help lower a person’s risk of developing the condition.
Although the exact cause of the disease has yet to be determined, Express reports that as early as now, people can make some lifestyle changes to lower their risk of developing the condition later on. The Institute for Scientific Information on Coffee reveals that drinking coffee can be beneficial in preventing neurodegenerative disorders that could happen in the later years. The team of researchers involved, led by Dr. Elisabet Rothenberg, analyzed previous studies on the links between dietary changes and neurological disorders such as Alzheimer’s and Parkinson’s.
According to their analysis, a higher intake of coffee will prevent the risk of developing the symptoms as well as alleviate the symptoms if already present. The suggested amount, Dr. Rothenberg says, is five cups of coffee a day can help protect the brain from neurodegenerative disorders in the future.
The association between caffeine and neurological disorders has yet to be defined, but this is still a step closer to further understanding of why it is. It will also further research into the benefits of coffee on a person.
On another note, the US National Library of Medicine National Institutes of Health also analyzed several studies regarding the caffeine found in coffee being associated with helping prevent dementia in the elderly. Out of five studies that were analyzed, three were found to support the effects of coffee on the nervous system. As tea also has caffeine content, two studies combined the effects of both coffee and tea on a person’s nervous system and found that the two drinks did help in cognitive functioning.
While there are already results linking the association between coffee and the prevention of dementia, there has yet to be results regarding tea having the same effect as coffee when protecting the brain against neurodegenerative diseases.
In one study, drinking three to five cups a day at midlife was linked to a decrease in developing dementia in the later years by 65 percent.


U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 



